TABLE 3.
Follow-up and recurrence
| Total |
||
|---|---|---|
| Factor | No. of cases | Value |
| Recurrent disease | 49 | 10 (20.4) |
|
| ||
| Follow-up time to recurrence, mo | 31 [23–26] | |
|
| ||
| Follow-up time, mo | 20 [21–23] | |
|
| ||
| Recurrence on first surveillance endoscopy/imaging | 10 | 5 (50) |
|
| ||
| Recurrence in curative resection patients | 10 | 0 (0) |
|
| ||
| Recurrence in noncurative resection patients | 39 | 10 (25.6) |
|
| ||
| Local recurrence alone | 49 | 5 (10.2) |
|
| ||
| Metastatic recurrence | 49 | 5 (10.2) |
|
| ||
| Regional lymph node metastases only | 2 (4.0) | |
|
| ||
| Distant metastases | 3 (6.1) | |
|
| ||
| All-cause mortality | 66 | 9 (13.6) |
Values are median [p25-p75] or n (%).